Terms: = Skin cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Treatment
10 results:
1. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/STAT3 signaling.
Zhong Z; Zhong H
Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
[TBL] [Abstract] [Full Text] [Related]
2. Combination of niclosamide and quinacrine inactivates Akt/hk2/Cyclin D1 axis mediated by glucose deprivation towards the inhibition of melanoma cell proliferation.
Li S; Wang D; Zheng X; Li Y; Ding C; Wang M; Ge X; Jiang J; Qiao Y; Wang Y
Biomed Pharmacother; 2023 Jul; 163():114865. PubMed ID: 37187020
[TBL] [Abstract] [Full Text] [Related]
3. Risks of malignancies among patients with psoriasis: A cohort study of 360 patients.
Watanabe T; Watanabe Y; Asai C; Asami M; Watanabe Y; Saigusa Y; Yamaguchi Y
J Dermatol; 2023 May; 50(5):615-621. PubMed ID: 36412216
[TBL] [Abstract] [Full Text] [Related]
4. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
Xie M; Xin C
Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
[TBL] [Abstract] [Full Text] [Related]
5. lncRNA RNCR2 facilitates cell proliferation and epithelial-mesenchymal transition in melanoma through hk2-mediated Warburg effect via targeting miR-495-3p.
Duan BX; Geng XR; Wu YQ
Neoplasma; 2021 Jul; 68(4):692-701. PubMed ID: 33724862
[TBL] [Abstract] [Full Text] [Related]
6. The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated hk2 and mTOR Signals.
Zhu Y; Liu M; Yao J; Guo Q; Wei L
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143000
[TBL] [Abstract] [Full Text] [Related]
7. Hexokinase2 controls angiogenesis in melanoma by promoting aerobic glycolysis and activating the p38-MAPK signaling.
Lu J; Liang X; Gao Y; Fu G; Shen Q
J Cell Biochem; 2019 Dec; 120(12):19721-19729. PubMed ID: 31270843
[TBL] [Abstract] [Full Text] [Related]
8. Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signaling.
Chen XY; Li DF; Han JC; Wang B; Dong ZP; Yu LN; Pan ZH; Qu CJ; Chen Y; Sun SG; Zheng QS
Oncotarget; 2017 May; 8(21):34565-34575. PubMed ID: 28410220
[TBL] [Abstract] [Full Text] [Related]
9. Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.
Samarakoon R; Helo S; Dobberfuhl AD; Khakoo NS; Falke L; Overstreet JM; Goldschmeding R; Higgins PJ
J Pathol; 2015 Aug; 236(4):421-32. PubMed ID: 25810340
[TBL] [Abstract] [Full Text] [Related]
10. Novel inhibitory activity for serine protease inhibitor Kazal type-3 (Spink3) on human recombinant kallikreins.
Assis DM; Zalazar L; Juliano MA; De Castro R; Cesari A
Protein Pept Lett; 2013 Oct; 20(10):1098-107. PubMed ID: 23590280
[TBL] [Abstract] [Full Text] [Related]
